Hagemann AR - Search Results

1

Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?

Garg G, Massad LS, Pourabolghasem S, Zhou G, Powell MA, Thaker PH, Hagemann AR, Wilkinson-Ryan I, Mutch DG. Garg G, et al. Among authors: hagemann ar. Gynecol Oncol. 2013 Jun;129(3):538-43. doi: 10.1016/j.ygyno.2013.03.004. Epub 2013 Mar 13. Gynecol Oncol. 2013. PMID: 23500088 Free PMC article.

2

Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.

Wright JD, Hagemann A, Rader JS, Viviano D, Gibb RK, Norris L, Mutch DG, Powell MA. Wright JD, et al. Cancer. 2006 Jul 1;107(1):83-9. doi: 10.1002/cncr.21969. Cancer. 2006. PMID: 16736514 Free article.

3

Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity.

Liao JB, Jean S, Wilkinson-Ryan I, Ford AE, Tanyi JL, Hagemann AR, Lin LL, McGrath CM, Rubin SC. Liao JB, et al. Among authors: hagemann ar. Gynecol Oncol. 2011 Jan;120(1):108-12. doi: 10.1016/j.ygyno.2010.09.005. Gynecol Oncol. 2011. PMID: 20937524

4

Cost-benefit of laparoscopic versus medical ovarian suppression in premenopausal breast cancer.

Hagemann AR, Zighelboim I, Odibo AO, Rader JS, Mutch DG, Powell MA. Hagemann AR, et al. Breast J. 2011 Jan-Feb;17(1):103-5. doi: 10.1111/j.1524-4741.2010.01017.x. Epub 2010 Dec 14. Breast J. 2011. PMID: 21155918 No abstract available.

5

Clinical predictors of bevacizumab-associated gastrointestinal perforation.

Tanyi JL, McCann G, Hagemann AR, Coukos G, Rubin SC, Liao JB, Chu CS. Tanyi JL, et al. Among authors: hagemann ar. Gynecol Oncol. 2011 Mar;120(3):464-9. doi: 10.1016/j.ygyno.2010.11.009. Epub 2010 Dec 17. Gynecol Oncol. 2011. PMID: 21168199

6

Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.

Garg G, Gao F, Wright JD, Hagemann AR, Mutch DG, Powell MA. Garg G, et al. Among authors: hagemann ar. Gynecol Oncol. 2013 Jan;128(1):77-82. doi: 10.1016/j.ygyno.2012.09.026. Epub 2012 Sep 29. Gynecol Oncol. 2013. PMID: 23032094 Free PMC article.

7

The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer.

Garg G, Gao F, Wright JD, Hagemann AR, Zighelboim I, Mutch DG, Powell MA. Garg G, et al. Among authors: hagemann ar. Int J Gynecol Cancer. 2013 Jan;23(1):90-7. doi: 10.1097/IGC.0b013e318275afd2. Int J Gynecol Cancer. 2013. PMID: 23196758 Free PMC article.

8

The utility and management of vaginal cytology after treatment for endometrial cancer.

Novetsky AP, Kuroki LM, Massad LS, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Zighelboim I. Novetsky AP, et al. Among authors: hagemann ar. Obstet Gynecol. 2013 Jan;121(1):129-35. doi: 10.1097/aog.0b013e31827499a9. Obstet Gynecol. 2013. PMID: 23262937 Free PMC article.

9

Discussion: 'Comparison of cervical cancer screening strategies,' by Cox et al.

Hagemann AR, Wilkinson-Ryan I, Kuroki LM, Squires K. Hagemann AR, et al. Am J Obstet Gynecol. 2013 Mar;208(3):e1-4. doi: 10.1016/j.ajog.2013.01.036. Epub 2013 Jan 24. Am J Obstet Gynecol. 2013. PMID: 23353021

10

Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins.

Ioffe YJ, Erickson BK, Foster KE, Mutch DG, Powell MA, Thaker PH, Hagemann AR, Conner MG, Huh WK, Massad LS. Ioffe YJ, et al. Among authors: hagemann ar. Gynecol Oncol. 2013 Jun;129(3):528-32. doi: 10.1016/j.ygyno.2013.02.033. Epub 2013 Mar 6. Gynecol Oncol. 2013. PMID: 23474347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters